Format

Send to

Choose Destination
Compr Ther. 2009 Fall-Winter;35(3-4):199-203.

Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.

Author information

1
Department of Medicine, West Virginia University, Morgantown, WV 26506-9162, USA. bchawla@hsc.wvu.edu

Abstract

Erythropoietin refractory anemias represent a continuing and increasing burden on the healthcare system. The current practice of providing these patients with rHuEPO does not seem to be working. Fewer than 50% of patients respond in some studies. We demonstrate that androgens have multiple benefits in this population. They control anemia and stop transfusion dependence and improve nutritional parameters. In some patients, they also have a salutary effect on both white blood cell and platelet counts.

PMID:
20043618
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center